Curated Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,561
Closed -$466K 134
2024
Q1
$466K Buy
+2,561
New +$441K 0.07% 90

Other funds holding ABBV

Curated Wealth Partners's ABBV Position: Q2 2026 in Review

Curated Wealth Partners increased its AbbVie (ABBV) stake by 17,090% in Q2 2026, buying an estimated $77.8M and bringing the position to 363,902 shares worth $1.59M. The position accounts for 0.21% of the portfolio, ranked #88.

Curated Wealth Partners first reported a position in ABBV in Q1 2021 and has held it in 21 quarters since. 1,645 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Curated Wealth Partners held 363,902 shares of AbbVie worth $1.59M as of Q2 2026.
  • Curated Wealth Partners bought 361,785 AbbVie shares in Q2 2026, an estimated $77.8M.
  • AbbVie made up 0.21% of Curated Wealth Partners's portfolio in Q2 2026, its #88 holding.
  • Curated Wealth Partners first reported a position in AbbVie in Q1 2021 and has held it in 21 quarters since.
  • 1,645 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.